Table 1.
Prognostic performance of individual HRneg/Tneg gene candidates in the HRneg training cohort (n = 199)
Affymetrix ID | Gene symbol | Gene title | Univariate Cox analysis | Multivariate Cox analysis | ||
---|---|---|---|---|---|---|
Coefficient | P value | Coefficient | P value | |||
204338_s_at | RGS4 | Regulator of G-protein signaling 4 | 0.24 | 2.64 × 10-3 | 0.16 | 0.12 |
205242_at | CXCL13 | Chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) | -0.19 | 1.90 × 10-5 | -0.16 | 6.0 × 10-4 |
205523_at | HAPLN1 | Hyaluronan and proteoglycan link protein 1 | 0.17 | 1.04 × 10-3 | 0.18 | 1.4 × 10-3 |
206821_x_at | HRBL | HIV-1 Rev binding protein-like | -0.48 | 6.96 × 10-4 | -0.22 | 0.18 |
206904_at | MATN1 | Matrilin 1, cartilage matrix protein | -0.50 | 8.97 × 10-5 | -0.11 | 0.45 |
207341_at | PRTN3 | Proteinase 3 (serine proteinase, neutrophil, Wegener granulomatosis autoantigen) | -0.41 | 2.64 × 10-4 | -0.12 | 0.37 |
207666_x_at | SSX3 | Synovial sarcoma, X breakpoint 3 | -0.33 | 2.17 × 10-3 | -0.42 | 5.8 × 10-4 |
208902_s_at | RPS28///ANKRD47 | Ribosomal protein S28///Ankyrin repeat domain 47 | -0.59 | 1.08 × 10-3 | -0.56 | 4.7 × 10-3 |
212035_s_at | EXOC7 | Exocyst complex component 7 | -0.58 | 2.47 × 10-4 | -0.42 | 2.4 × 10-2 |
216929_x_at | ABO | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) | -0.44 | 3.26 × 10-4 | -0.23 | 9.2 × 10-2 |
217628_at | CLIC5 | Chloride intracellular channel 5///similar to chloride intracellular channel 5 | -0.48 | 1.89 × 10-4 | -0.24 | 0.13 |
218430_s_at | RFXDC2 | Regulatory factor X domain containing 2 | -0.47 | 2.57 × 10-4 | -0.40 | 4.6 × 10-3 |
219605_at | ZNF3 | Zinc finger protein 3 | -0.34 | 4.85 × 10-3 | -0.30 | 4.5 × 10-2 |
220433_at | PRRG3 | Proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane) | -0.47 | 4.95 × 10-4 | -0.27 | 6.2 × 10-2 |
HRneg, hormone receptor-negative; Tneg, triple-negative.